# Evaluating Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery

> **NCT07730294** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Yale University** · enrollment: 75 (estimated)

## Conditions studied

- Pain
- Pituitary Surgery

## Interventions

- **DRUG:** Oxytocin (Low dose)
- **DRUG:** Oxytocin (High dose)
- **DRUG:** Placebo (saline)

## Key facts

- **NCT ID:** NCT07730294
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2028-08
- **Final completion:** 2028-08
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07730294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07730294, "Evaluating Intranasal Oxytocin (TNX-1900) for Pain Relief and Recovery After Pituitary Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07730294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*